TC Biopharm (Holdings) Plc (TCBP)

$4.97

-0.15 (-2.93%)
Rating:
Recommendation:
-
Symbol TCBP
Price $4.97
Beta 0.000
Volume Avg. 1.06M
Market Cap 3.951M
Shares () -
52 Week Range 2.81-175.0
1y Target Est -
DCF Unlevered TCBP DCF ->
DCF Levered TCBP LDCF ->
ROE 66.20% Strong Buy
ROA -38.47% Strong Sell
Operating Margin -
Debt / Equity 1232.12% Strong Buy
P/E -
P/B 2 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Healthcare
Biotechnology
NASDAQ Capital Market

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.